カリフォルニア州における筋炎の臨床試験
カリフォルニア州内の拠点で、筋炎に関する11件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of California Irvine - Accepting Adult Patients, Orange
- University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients, San Francisco
被験者募集中第2/3相
6歳〜75歳 · 全性別 · 2026/09/17更新 · NCT06154252A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/09/15更新 · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- 200 UCLA Medical Plaza, Los Angeles
- UCLA Clinical & Translational Research Center (CTRC), Los Angeles
- UCLA, Los Angeles
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/09/02更新 · NCT07800871A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/08/28更新 · NCT06925542Descartes-08 in Autoantibody Myositis
- University of California, Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07391605A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Orange
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/08/07更新 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Chula Vista, Chula Vista
- Artiva Investigational Site Covina, Covina
- Artiva Investigational Site Los Alamitos, Los Alamitos
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT06991114A Study of AZD0120 in Autoimmune Diseases
- Research Site, Stanford
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07295847A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- 他2件
被験者募集中第1相
12歳〜70歳 · 全性別 · 2026/05/22更新 · NCT06308978ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。